Becton Dickinson Total Long-Term Assets 2010-2024 | BDX
Becton Dickinson total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
- Becton Dickinson total long-term assets for the quarter ending September 30, 2024 were $43.375B, a 2.37% decline year-over-year.
- Becton Dickinson total long-term assets for 2023 were $44.105B, a 1.53% decline from 2022.
- Becton Dickinson total long-term assets for 2022 were $44.791B, a 0.53% decline from 2021.
- Becton Dickinson total long-term assets for 2021 were $45.03B, a 0.03% decline from 2020.
Becton Dickinson Annual Total Long-Term Assets
(Millions of US $) |
| 2023 |
$44,105 |
| 2022 |
$44,791 |
| 2021 |
$45,030 |
| 2020 |
$45,043 |
| 2019 |
$45,101 |
| 2018 |
$46,494 |
| 2017 |
$19,101 |
| 2016 |
$19,221 |
| 2015 |
$20,818 |
| 2014 |
$6,317 |
| 2013 |
$6,277 |
| 2012 |
$6,039 |
| 2011 |
$5,762 |
| 2010 |
$5,145 |
| 2009 |
$4,658 |
Becton Dickinson Quarterly Total Long-Term Assets
(Millions of US $) |
| 2024-06-30 |
$43,375 |
| 2024-03-31 |
$43,816 |
| 2023-12-31 |
$44,117 |
| 2023-09-30 |
$44,105 |
| 2023-06-30 |
$44,430 |
| 2023-03-31 |
$44,807 |
| 2022-12-31 |
$44,955 |
| 2022-09-30 |
$44,791 |
| 2022-06-30 |
$43,653 |
| 2022-03-31 |
$44,635 |
| 2021-12-31 |
$45,056 |
| 2021-09-30 |
$45,030 |
| 2021-06-30 |
$44,796 |
| 2021-03-31 |
$44,920 |
| 2020-12-31 |
$45,212 |
| 2020-09-30 |
$45,043 |
| 2020-06-30 |
$45,131 |
| 2020-03-31 |
$44,961 |
| 2019-12-31 |
$45,515 |
| 2019-09-30 |
$45,101 |
| 2019-06-30 |
$45,452 |
| 2019-03-31 |
$45,754 |
| 2018-12-31 |
$45,991 |
| 2018-09-30 |
$46,494 |
| 2018-06-30 |
$46,452 |
| 2018-03-31 |
$47,061 |
| 2017-12-31 |
$47,821 |
| 2017-09-30 |
$19,101 |
| 2017-06-30 |
$18,953 |
| 2017-03-31 |
$19,229 |
| 2016-12-31 |
$19,130 |
| 2016-09-30 |
$19,221 |
| 2016-06-30 |
$19,481 |
| 2016-03-31 |
$19,624 |
| 2015-12-31 |
$20,405 |
| 2015-09-30 |
$20,818 |
| 2015-06-30 |
$20,776 |
| 2015-03-31 |
$21,298 |
| 2014-12-31 |
$6,392 |
| 2014-09-30 |
$6,317 |
| 2014-06-30 |
$6,329 |
| 2014-03-31 |
$6,304 |
| 2013-12-31 |
$6,291 |
| 2013-09-30 |
$6,277 |
| 2013-06-30 |
$6,153 |
| 2013-03-31 |
$6,130 |
| 2012-12-31 |
$6,152 |
| 2012-09-30 |
$6,039 |
| 2012-06-30 |
$5,740 |
| 2012-03-31 |
$5,895 |
| 2011-12-31 |
$5,719 |
| 2011-09-30 |
$5,762 |
| 2011-06-30 |
$5,548 |
| 2011-03-31 |
$5,488 |
| 2010-12-31 |
$5,120 |
| 2010-09-30 |
$5,145 |
| 2010-06-30 |
$4,909 |
| 2010-03-31 |
$5,004 |
| 2009-12-31 |
$5,037 |
| 2009-09-30 |
$4,658 |
| 2009-06-30 |
$4,357 |
| 2009-03-31 |
$4,168 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$64.352B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
